320 related articles for article (PubMed ID: 16041534)
1. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.
Wezenberg E; Verkes RJ; Sabbe BG; Ruigt GS; Hulstijn W
Psychopharmacology (Berl); 2005 Sep; 181(3):582-94. PubMed ID: 16041534
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic enhancement of episodic memory in healthy young adults.
Grön G; Kirstein M; Thielscher A; Riepe MW; Spitzer M
Psychopharmacology (Berl); 2005 Oct; 182(1):170-9. PubMed ID: 16021483
[TBL] [Abstract][Full Text] [Related]
3. Biperiden Selectively Impairs Verbal Episodic Memory in a Dose- and Time-Dependent Manner in Healthy Subjects.
Borghans L; Sambeth A; Blokland A
J Clin Psychopharmacol; 2020; 40(1):30-37. PubMed ID: 31834098
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants.
Klinkenberg I; Blokland A; Riedel WJ; Sambeth A
Psychopharmacology (Berl); 2013 Feb; 225(4):903-21. PubMed ID: 23052568
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers.
Wezenberg E; Verkes RJ; Ruigt GS; Hulstijn W; Sabbe BG
Neuropsychopharmacology; 2007 Jun; 32(6):1272-83. PubMed ID: 17119538
[TBL] [Abstract][Full Text] [Related]
6. Effects of biperiden and acute tryptophan depletion and their combination on verbal word memory and EEG.
Borghans LG; Blokland A; Sambeth A
Psychopharmacology (Berl); 2017 Apr; 234(7):1135-1143. PubMed ID: 28210777
[TBL] [Abstract][Full Text] [Related]
7. Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram.
Sambeth A; Riedel WJ; Klinkenberg I; Kähkönen S; Blokland A
Psychopharmacology (Berl); 2015 Jun; 232(11):1887-97. PubMed ID: 25466702
[TBL] [Abstract][Full Text] [Related]
8. Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.
Bakker C; van Esdonk MJ; Stuurman RFE; Borghans LGJM; de Kam ML; van Gerven JMA; Groeneveld GJ
J Clin Pharmacol; 2021 Nov; 61(11):1466-1478. PubMed ID: 34021607
[TBL] [Abstract][Full Text] [Related]
9. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.
Mahoney JJ; Kalechstein AD; Verrico CD; Arnoudse NM; Shapiro BA; De La Garza R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():137-42. PubMed ID: 24239594
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.
Miettinen PS; Pihlajamäki M; Jauhiainen AM; Tarkka IM; Gröhn H; Niskanen E; Hänninen T; Vanninen R; Soininen H
Curr Alzheimer Res; 2011 Nov; 8(7):753-64. PubMed ID: 21592058
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.
Theunissen EL; Heckman P; de Sousa Fernandes Perna EB; Kuypers KP; Sambeth A; Blokland A; Prickaerts J; Toennes SW; Ramaekers JG
Psychopharmacology (Berl); 2015 Jan; 232(2):343-53. PubMed ID: 24998257
[TBL] [Abstract][Full Text] [Related]
12. The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment.
Borghans LGJM; Sambeth A; Prickaerts J; Ramaekers JG; Blokland A
Psychopharmacology (Berl); 2018 Aug; 235(8):2407-2416. PubMed ID: 29882087
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
McKeith I; Del Ser T; Spano P; Emre M; Wesnes K; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
Lancet; 2000 Dec; 356(9247):2031-6. PubMed ID: 11145488
[TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Sharma T; Reed C; Aasen I; Kumari V
Schizophr Res; 2006 Jul; 85(1-3):73-83. PubMed ID: 16797163
[TBL] [Abstract][Full Text] [Related]
15. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
[TBL] [Abstract][Full Text] [Related]
16. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
Zugno AI; Julião RF; Budni J; Volpato AM; Fraga DB; Pacheco FD; Deroza PF; Luca RD; de Oliveira MB; Heylmann AS; Quevedo J
Metab Brain Dis; 2013 Sep; 28(3):501-8. PubMed ID: 23775300
[TBL] [Abstract][Full Text] [Related]
17. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
[TBL] [Abstract][Full Text] [Related]
18. Mnemonic and behavioral effects of biperiden, an M1-selective antagonist, in the rat.
Popelíková A; Bahník Š; Lobellová V; Svoboda J; Stuchlík A
Psychopharmacology (Berl); 2018 Jul; 235(7):2013-2025. PubMed ID: 29680966
[TBL] [Abstract][Full Text] [Related]
19. Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
Wesnes KA; McKeith IG; Ferrara R; Emre M; Del Ser T; Spano PF; Cicin-Sain A; Anand R; Spiegel R
Dement Geriatr Cogn Disord; 2002; 13(3):183-92. PubMed ID: 11893841
[TBL] [Abstract][Full Text] [Related]
20. The effect of the muscarinic M
Vingerhoets C; Bakker G; van Dijk J; Bloemen OJN; Wang Y; Chan RCK; Booij J; van Amelsvoort TAMJ
Eur Neuropsychopharmacol; 2017 Sep; 27(9):854-864. PubMed ID: 28689687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]